CTLA4 and pemphigus vulgaris: Emerging reports on the appearance of newly acquired pemphigus vulgaris or exacerbation of pre-existing pemphigus disease under both PD-1/PD-L1 and CTLA-4 inhibitors are also present in the literature [50,51,52].